Search results for abx831369
Showing 1 – 10 of1products
ID: BAB289488320
Refanezumab, Abbexa, abx831369
Refanezumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting MAG/SIGLEC-4A, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Refanezumab is under investigation in clinical trial NCT00833989 (Safety Escalating Repeat IV, in Stroke Patients).
Host
Human
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Request a product
Please provide the required information below so that we can quickly source your products.